Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Intervention Indication Therapeutic Area Year Actions
Mepolizumab add-on therapy for chronic obstructive pulmonary disease with eosinophil-associated exacerbations Mepolizumab (Nucala; SB-240563; SB-240563 autoinjector) Chronic obstructive pulmonary disease (COPD) Respiratory System 2024 View  |  Download
Mepolizumab for chronic rhinosinusitis with nasal polyposis,in addition to standard care Mepolizumab (Nucala; SB-240563; SB-240563 autoinjector) Nasal polyps Ear Nose and Throat (ENT) 2020 View  |  Download
Mepolizumab for hypereosinophilic syndrome – add-on therapy Mepolizumab (Nucala; SB-240563; SB-240563 autoinjector) Hypereosinophilic syndrome (HES) Immunology 2020 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications